Anne-Vibeke Lænkholm

Anne-Vibeke Lænkholm

Clinical Associate Professor


  1. 2018
  2. Published

    The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer

    Jensen, M., Lænkholm, Anne-Vibeke, Nielsen, T. O., Eriksen, J. O., Wehn, P., Hood, T., Ram, N., Buckingham, W., Ferree, S. & Ejlertsen, B., 2018, In: Breast cancer research : BCR. 20, 10 p., 79.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes

    Lænkholm, Anne-Vibeke, Jensen, M., Eriksen, J. O., Buckingham, W., Ferree, S., Nielsen, T. O. & Ejlertsen, B., 2018, In: Acta Oncologica. 57, 1, p. 44-50

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007–2016

    Jensen, M. B., Lænkholm, Anne-Vibeke, Offersen, B. V., Christiansen, P., Kroman, Niels Thorndahl, Mouridsen, H. T. & Ejlertsen, B., 2018, In: Acta Oncologica. 57, 1, p. 13-18

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D3

    Lundqvist, J., Kirkegaard, T., Lænkholm, Anne-Vibeke, Duun-Henriksen, A. K., Bak, M., Feldman, D. & Lykkesfeldt, A. E., 2018, In: The Journal of Steroid Biochemistry and Molecular Biology. 177, p. 171-178

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 102813499